<?xml version="1.0" encoding="UTF-8"?>
<ref id="B160-molecules-25-03846">
 <label>160.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jones</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Rupert</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Poi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Phelps</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Andritsos</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Baiocchi</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Benson</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Blum</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Christian</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Flynn</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkinâ€™s lymphoma</article-title>
  <source>Am. J. Hematol.</source>
  <year>2014</year>
  <volume>89</volume>
  <fpage>19</fpage>
  <lpage>24</lpage>
  <pub-id pub-id-type="doi">10.1002/ajh.23568</pub-id>
  <?supplied-pmid 23959599?>
  <pub-id pub-id-type="pmid">23959599</pub-id>
 </element-citation>
</ref>
